Randomized controlled Phase III study comparing hepatic arterial infusion with systemic chemotherapy after curative resection for liver metastasis of colorectal carcinoma: JFMC 29–0003

Weiss, 1986, J Pathol, Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies, 195

Fong, 1997, J Clin Oncol, Liver resection for colorectal metastases, 938

Choti, 2002, Ann Surg, Trends in long-term survival following liver resection for hepatic colorectal metastases, 759

Hughes, 1986, Surgery, Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence, 278

Hayashi, 1999, Surgery, No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer, 369

Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974;75:589-96.

Conway, 1983, Cancer Res, Effect of size on portal circulation of hepatic nodules from carcinogen-treated rats, 3374

Archer, 1989, Br J Surg, Vascularization of small liver metastases, 545

Taylor, 1979, Br J Surg, Adjuvant cytotoxic liver perfusion for colorectal cancer, 833

Kemeny, 2006, J Clin Oncol, Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481), 1395

Rougier, 1992, J Clin Oncol, Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial, 1112

Allen-Mersh, 1994, Lancet, Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases, 1255

Tono, 2000, Cancer, Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study, 1549

Kemeny, 1999, N Engl J Med, Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer, 2039

Heinrich, 2003, Surgery, Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases, 40

Matsumoto, 2002, Qual Life Res, The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): Validity and reliability in Japanese patients with advanced non-small-cell lung cancer, 483

Goéré, 2013, Ann Surg, Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: A comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy, 114

Kemeny, 2009, Ann Oncol, Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer, 1236

Alberts, 2010, J Clin Oncol, Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: A North Central Cancer Treatment Group (NCCTG)/National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66, 853

Ensminger, 1978, Cancer Res, A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil, 3784

Campbell, 1993, J Clin Oncol, Regional chemotherapy devices: Effect of experience and anatomy on complications, 822

Sadahiro, 2013, Surg Today, Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer, 1088

Yothers, 2011, J Clin Oncol, Oxaliplatin as adjuvant therapy for colon cancer: Updated results of NSABP C-07 trial, including survival and subset analyses, 3768

Kuebler, 2007, J Clin Oncol, Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07, 2198

Schmoll, 2007, J Clin Oncol, Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: A planned safety analysis in 1,864 patients, 102

Kemeny, 2011, J Clin Oncol, Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer, 884

Nordlinger, 2013, Lancet Oncol, Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial, 1208